These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22922799)

  • 1. Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
    Meng Q; Garcia-Rodriguez C; Manzanarez G; Silberg MA; Conrad F; Bettencourt J; Pan X; Breece T; To R; Li M; Lee D; Thorner L; Tomic MT; Marks JD
    Anal Biochem; 2012 Nov; 430(2):141-50. PubMed ID: 22922799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein.
    Meng Q; Li M; Silberg MA; Conrad F; Bettencourt J; To R; Huang C; Ma J; Meyer K; Shimizu R; Cao L; Tomic MT; Marks JD
    Anal Biochem; 2012 Feb; 421(2):351-61. PubMed ID: 22037290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
    Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
    Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
    PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A.
    Corbett CR; Ballegeer E; Weedmark KA; Elias MD; Al-Saleem FH; Ancharski DM; Simpson LL; Berry JD
    Hybridoma (Larchmt); 2011 Dec; 30(6):503-10. PubMed ID: 22149274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk.
    Scotcher MC; Cheng LW; Stanker LH
    PLoS One; 2010 Jun; 5(6):e11047. PubMed ID: 20548779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
    Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
    Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
    Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.
    Chen F; Kuziemko GM; Amersdorfer P; Wong C; Marks JD; Stevens RC
    Infect Immun; 1997 May; 65(5):1626-30. PubMed ID: 9125539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
    Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
    PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant H(C) and H(N) fragments from Clostridium botulinum neurotoxin types C(1) and D.
    Curran RM; Fringuelli E; Graham D; Elliott CT
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):1-10. PubMed ID: 19233482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E.
    Bever CS; Scotcher M; Cheng LW; Hnasko RM; Stanker LH
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31337022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
    Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.
    Nayak SU; Griffiss JM; McKenzie R; Fuchs EJ; Jurao RA; An AT; Ahene A; Tomic M; Hendrix CW; Zenilman JM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5047-53. PubMed ID: 24913160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
    Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
    PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.
    Pless DD; Torres ER; Reinke EK; Bavari S
    Infect Immun; 2001 Jan; 69(1):570-4. PubMed ID: 11119555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.